157 related articles for article (PubMed ID: 10470291)
1. Membrane transport and antitumor activity of pirarubicin, and comparison with those of doxorubicin.
Sugiyama T; Sadzuka Y; Nagasawa K; Ohnishi N; Yokoyama T; Sonobe T
Jpn J Cancer Res; 1999 Jul; 90(7):775-80. PubMed ID: 10470291
[TBL] [Abstract][Full Text] [Related]
2. Enhancing effects of green tea components on the antitumor activity of adriamycin against M5076 ovarian sarcoma.
Sugiyama T; Sadzuka Y
Cancer Lett; 1998 Nov; 133(1):19-26. PubMed ID: 9929156
[TBL] [Abstract][Full Text] [Related]
3. Relationships between the in vitro cytotoxicity and transport characteristics of pirarubicin and doxorubicin in M5076 ovarian sarcoma cells, and comparison with those in Ehrlich ascites carcinoma cells.
Nagai K; Nagasawa K; Sadzuka Y; Tsujimoto M; Takara K; Ohnishi N; Yokoyama T; Fujimoto S
Cancer Chemother Pharmacol; 2002 Mar; 49(3):244-50. PubMed ID: 11935217
[TBL] [Abstract][Full Text] [Related]
4. Combination of theanine with doxorubicin inhibits hepatic metastasis of M5076 ovarian sarcoma.
Sugiyama T; Sadzuka Y
Clin Cancer Res; 1999 Feb; 5(2):413-6. PubMed ID: 10037191
[TBL] [Abstract][Full Text] [Related]
5. Uptake of the anthracycline pirarubicin into mouse M5076 ovarian sarcoma cells via a sodium-dependent nucleoside transport system.
Nagai K; Nagasawa K; Fujimoto S
Cancer Chemother Pharmacol; 2005 Mar; 55(3):222-30. PubMed ID: 15526202
[TBL] [Abstract][Full Text] [Related]
6. Theanine and glutamate transporter inhibitors enhance the antitumor efficacy of chemotherapeutic agents.
Sugiyama T; Sadzuka Y
Biochim Biophys Acta; 2003 Dec; 1653(2):47-59. PubMed ID: 14643924
[TBL] [Abstract][Full Text] [Related]
7. Pronounced Cellular Uptake of Pirarubicin versus That of Other Anthracyclines: Comparison of HPMA Copolymer Conjugates of Pirarubicin and Doxorubicin.
Nakamura H; Koziolová E; Chytil P; Tsukigawa K; Fang J; Haratake M; Ulbrich K; Etrych T; Maeda H
Mol Pharm; 2016 Dec; 13(12):4106-4115. PubMed ID: 27934482
[TBL] [Abstract][Full Text] [Related]
8. Modulation of cancer chemotherapy by green tea.
Sadzuka Y; Sugiyama T; Hirota S
Clin Cancer Res; 1998 Jan; 4(1):153-6. PubMed ID: 9516964
[TBL] [Abstract][Full Text] [Related]
9. Transport mechanism of anthracycline derivatives in rat polymorphonuclear leukocytes: uptake and efflux of pirarubicin.
Nagasawa K; Nomiyama M; Ohnishi N; Yokoyama T; Iwakawa S; Okumura K
Biol Pharm Bull; 1994 May; 17(5):696-700. PubMed ID: 7920436
[TBL] [Abstract][Full Text] [Related]
10. [Glutamate transporter mediated increase of antitumor activity by theanine, an amino acid in green tea].
Sadzuka Y; Yamashita Y; Kishimoto S; Fukushima S; Takeuchi Y; Sonobe T
Yakugaku Zasshi; 2002 Nov; 122(11):995-9. PubMed ID: 12440157
[TBL] [Abstract][Full Text] [Related]
11. Transport mechanism of anthracycline derivatives in human leukemia cell lines: uptake and efflux of pirarubicin in HL60 and pirarubicin-resistant HL60 cells.
Nagasawa K; Natazuka T; Chihara K; Kitazawa F; Tsumura A; Takara K; Nomiyama M; Ohnishi N; Yokoyama T
Cancer Chemother Pharmacol; 1996; 37(4):297-304. PubMed ID: 8548874
[TBL] [Abstract][Full Text] [Related]
12. Transport mechanism of anthracycline derivatives in rat polymorphonuclear leukocytes: uptake of pirarubicin, daunorubicin and doxorubicin.
Nagasawa K; Nomiyama M; Ohnishi N; Yokoyama T; Iwakawa S; Okumura K
Biol Pharm Bull; 1994 Sep; 17(9):1305-8. PubMed ID: 7841960
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of glutamate transporter by theanine enhances the therapeutic efficacy of doxorubicin.
Sugiyama T; Sadzuka Y; Tanaka K; Sonobe T
Toxicol Lett; 2001 Apr; 121(2):89-96. PubMed ID: 11325559
[TBL] [Abstract][Full Text] [Related]
14. Contribution of an unidentified sodium-dependent nucleoside transport system to the uptake and cytotoxicity of anthracycline in mouse M5076 ovarian sarcoma cells.
Nagai K; Nagasawa K; Koma M; Kihara Y; Fujimoto S
Biochem Pharmacol; 2006 Feb; 71(5):565-73. PubMed ID: 16376308
[TBL] [Abstract][Full Text] [Related]
15. [Augmentation of pirarubicin cytotoxicity by chlorpromazine in doxorubicin-resistant mouse P388 leukemia cells].
Shibata H; Sano F; Furusawa S; Kawauchi H; Sasaki K; Takayanagi Y
Yakugaku Zasshi; 1990 Sep; 110(9):678-81. PubMed ID: 2262880
[TBL] [Abstract][Full Text] [Related]
16. [Modulation of anthracycline resistance by reserpine in P388 leukemia cells].
Shibata H; Furusawa S; Kawauchi H; Sasaki K; Takayanagi Y
Nihon Yakurigaku Zasshi; 1991 Jul; 98(1):1-6. PubMed ID: 1889760
[TBL] [Abstract][Full Text] [Related]
17. Thermal enhancement of pirarubicin (THP-adriamycin) by mild hyperthermia in vitro.
Takahashi T; Mitsuhashi N; Sakurai H; Murata O; Kitamoto Y; Matsumoto H; Higuchi K; Niibe H
Int J Hyperthermia; 1997; 13(3):317-24. PubMed ID: 9222814
[TBL] [Abstract][Full Text] [Related]
18. Enhancement of the activity of doxorubicin by inhibition of glutamate transporter.
Sadzuka Y; Sugiyama T; Suzuki T; Sonobe T
Toxicol Lett; 2001 Sep; 123(2-3):159-67. PubMed ID: 11641044
[TBL] [Abstract][Full Text] [Related]
19. Screening of biochemical modulator by tumor cell permeability of doxorubicin.
Sadzuka Y; Hatakeyama H; Daimon T; Sonobe T
Int J Pharm; 2008 Apr; 354(1-2):63-9. PubMed ID: 18054183
[TBL] [Abstract][Full Text] [Related]
20. In vivo antitumor activity and host toxicity of methoxymorpholinyl doxorubicin: role of cytochrome P450 3A.
Quintieri L; Rosato A; Napoli E; Sola F; Geroni C; Floreani M; Zanovello P
Cancer Res; 2000 Jun; 60(12):3232-8. PubMed ID: 10866316
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
